Regulating dodgy stem cell clinics: FDA is appealing against ruling

The US Food and Drug Administration (FDA) has decided to appeal a surprising decision after it lost a case it was fighting against a California stem cell clinic. The appeal was made against a decision by a California District Court that the California Stem Cell Treatment Center (CSCTC)’s medical procedure that utilises patients’ personal stem cells does not fall under the FDA’s authority. Conflicting rulings about stem cell treatments could raise questions about the FDA’s authority. If the 9th Circuit were to support the district court’s ruling, the resulting circuit split could challenge FDA’s authority to regulate such unscrupulous businesses.